In the BioHarmony Drug Report Database
Ospemifene
Osphena, Senshio (ospemifene) is a small molecule pharmaceutical. Ospemifene was first approved as Osphena on 2013-02-26. It is used to treat atrophy, dyspareunia, and menopause in the USA. It has been approved in Europe to treat postmenopause. Osphena’s patents are valid until 2028-07-09 (FDA).
Trade Name
|
Senshio |
|---|---|
Common Name
|
ospemifene |
ChEMBL ID
|
CHEMBL2105395 |
Indication
|
atrophy, dyspareunia, menopause, postmenopause |
Drug Class
|
Antiestrogens of the clomifene and tamoxifen groups |
Image (chem structure or protein)